TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2014

Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer.

Alberto Chiappori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.